IDO1-IN-5

CAS No. 2166616-75-5

IDO1-IN-5( —— )

Catalog No. M22853 CAS No. 2166616-75-5

IDO1-IN-5 is a selective, potent and brain penetrated inhibitor of IDO1 activity, binds to apo-IDO1 lacking heme rather than mature heme-bound IDO1.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 65 In Stock
2MG 46 In Stock
5MG 75 In Stock
10MG 126 In Stock
25MG 215 In Stock
50MG 338 In Stock
100MG 528 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    IDO1-IN-5
  • Note
    Research use only, not for human use.
  • Brief Description
    IDO1-IN-5 is a selective, potent and brain penetrated inhibitor of IDO1 activity, binds to apo-IDO1 lacking heme rather than mature heme-bound IDO1.
  • Description
    IDO1-IN-5 is a selective, potent and brain penetrated inhibitor of IDO1 activity, binds to apo-IDO1 lacking heme rather than mature heme-bound IDO1.
  • In Vitro
    LY-3381916 (IDO1-IN-5) (up to 100 μM) shows no obvious agonism of aryl hydrocarbon receptor (AHR).
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    IDO
  • Recptor
    IDO1
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2166616-75-5
  • Formula Weight
    396.45
  • Molecular Formula
    C23H25FN2O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:300 mg/mL (756.72 mM; Need ultrasonic)
  • SMILES
    FC1=CC=C(C(N[C@H](C)C2=CC=C(N(C(C3CCOCC3)=O)CC4)C4=C2)=O)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Frank C. Dorsey, et al. Abstract 5245: Identification and characterization of the IDO1 inhibitor LY3381916. Cancer Research. 2018, 78(13).
molnova catalog
related products
  • Navoximod

    Navoximod (NLG-?919, GDC-0919) is a potent indoleamine-(2,3)-dioxygenase (IDO) pathway inhibitor (Ki/EC50: 7 nM/75 nM).

  • NLG919

    NLG919 is a potent IDO (indoleamine-(2,3)-dioxygenase) pathway inhibitor with Ki/EC50 of 7 nM/75 nM in cell-free assays. Phase 1.

  • IDO-IN-12

    IDO-IN-12 is an inhibitor of indoleamine 2,3-dioxygenase (IDO).